ENTITY
Hutchmed China Ltd

Hutchmed China Ltd (13 HK)

202
Analysis
IndustrialsHong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
11 Aug 2021 09:00

Pre-IPO Asymchem Laboratories - The Strength and the Concerns

The article mainly analyzed Asymchem Laboratories in terms of the industry characteristics, the strength of its business, the comparison with...

Logo
427 Views
Share
27 Jul 2021 10:03

Asymchem Labs A/H Listing Early Look - Fast Growing, Relatively Insulated

Asymchem Laboratories (002821 CH) (AL) aims to raise around US$1-1.5bn in its H-share listing in Hong Kong. The A-shares listed were listed in...

Logo
382 Views
Share
bullishWuxi Biologics
20 Jul 2021 18:54

Wuxi Biologics Placement - Similar Deal Will Yield Similar Results

Wuxi Biologics Holdings is looking to raise up to US$1.3bn by selling about 1.8% of Wuxi Biologics (2269 HK). This is the company's 15th placement...

Logo
505 Views
Share
29 Jun 2021 15:35

HCM Secondary Trading: NPMA Approvals Warrant a Pop on Debut

We look updates from HCM since it launched its book building. We note that the recent NMPA approval will result in a share price pop on debut.

Logo
296 Views
Share
27 Jun 2021 08:56

China Healthcare Weekly (Jun.25)

This article analyzed the results of 5th national volume-based purchase, the new announcement on the centralized procurement of artificial joints,...

Logo
316 Views
Share
x